Table 3

Concentration of cholesterol, triglyceride, phospoholipid, and protein of each lipoprotein subfraction and their total mass for patients with psoriatic arthritis and controls (n=13). Results are expressed as means (SEM). Units mg/dl

Total cholesterolTriglyceridePhospholipidProteinTotal mass
PatientControlPatientControlPatientControlPatientControlPatientControl
Chylomicrons0.12 (0.03)0.11 (0.02)0.36 (0.13)0.45 (0.14)0.05 (0.01)3-150 0.37 (0.15)3-150 0.18 (0.03)0.35 (0.18)0.65 (0.16)1.28 (0.29)
VLDL1 1.82 (0.59)1.05 (0.27)14.5 (4.44)7.62 (1.48)2.8 (0.9)1.06 (0.2)1.81 (0.59)1.19 (0.32)20.94 (6.49)10.92 (1.99)
VLDL2 3.09 (1.05)2.08 (0.41)15.5 (4.48)11.62 (2.09)4.2 (1.3)2.46 (0.33)2.99 (0.89)2.1 (0.34)30.65 (18.35)12.38 (3.03)
VLDL3 9.67 (2.66)7.79 (1.43)20.88 (4.83)16.38 (1.94)9.89 (2.37)7.03 (1.05)7.0 (1.88)6.0 (0.85)45.22 (12.04)35.52 (3.96)
LDL1 13.95 (1.85)15.24 (1.86)9.49 (1.15)7.68 (0.81)9.99 (1.12)9.12 (1.25)9.56 (0.9)9.03 (0.97)42.99 (4.51)41 (4.51)
LDL2 55.92 (2.99)65.96 (4.92)10.77 (1.33)8.48 (1.03)34.49 (3.17)37.59 (2.95)39.95 (1.96)40.99 (2.66)142.8 (9.46)153.6 (9.97)
LDL3 25.59 (3.81)3-160 14.53 (0.79)3-160 4.02 (0.67)3-160 1.92 (0.23)3-160 13.98 (3.39)3-150 7.28 (0.72)3-150 20.74 (3.42)3-150 11.92 (0.91)3-150 61.9 (10.61)3-150 35.65 (2.18)3-150
  • Significant results for patients with psoriatic arthritisv controls:

  • 3-150 p<0.05;

  • 3-160 p<0.01.